# Integrated Transcriptomic and Histological Analysis of TP53/CTNNB1 Mutations and Microvascular Invasion in Hepatocellular Carcinoma

**Authors:** Ignacio Garach, Nerea Hernandez, Luis J. Herrera, Francisco M. Ortuño, Ignacio Rojas

PMC · DOI: 10.3390/genes17020190 · Genes · 2026-02-03

## TL;DR

This study links genetic mutations and tumor features in liver cancer to both gene activity and visible patterns in tissue samples.

## Contribution

The study integrates transcriptomic and histological data to show how TP53/CTNNB1 mutations and MVI relate to observable tumor patterns.

## Key findings

- TP53-mutated, CTNNB1-mutated, and MVI-positive tumors have distinct gene expression profiles linked to proliferation and invasion.
- Deep learning models detected histological patterns associated with these molecular states from whole-slide images.
- Phenotypic effects of key HCC risk factors are partially detectable in routine histopathology.

## Abstract

Background/Objectives: Hepatocellular carcinoma (HCC) shows marked molecular and histopathological heterogeneity. Among the alterations most strongly associated with clinical outcome are mutations in TP53 and CTNNB1, as well as the presence of microvascular invasion (MVI). Although these factors are well established as prognostic indicators, how their molecular effects relate to tumor morphology remains unclear. In this work, we studied transcriptomic changes linked to TP53 and CTNNB1 mutational status and to MVI, and examined whether these changes are reflected in routine histology. Methods: RNA sequencing data from HCC samples annotated for mutations and vascular invasion were analyzed using differential expression analysis combined with machine learning-based feature selection to characterize the underlying transcriptional programs. In parallel, we trained a weakly supervised multitask deep learning model on hematoxylin and eosin-stained whole-slide images using slide-level labels only, without spatial annotations, to assess whether these features could be inferred from global histological patterns. Results: Distinct gene expression profiles were observed for TP53-mutated, CTNNB1-mutated, and MVI-positive tumors, involving pathways related to proliferation, metabolism, and invasion. Image-based models were able to capture morphological patterns associated with these states, achieving above-random discrimination with variable performance across tasks. Conclusions: Taken together, these results support the existence of coherent biological programs underlying key risk determinants in HCC and indicate that their phenotypic effects are, at least in part, detectable in routine histopathology. This provides a rationale for integrative morpho-molecular approaches to risk assessment in HCC.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], CTNNB1 (catenin beta 1) [NCBI Gene 1499]
- **Diseases:** Hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** CDCA8 (cell division cycle associated 8) [NCBI Gene 55143] {aka BOR, BOREALIN, DasraB, MESRGP}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, SLC22A12 (solute carrier family 22 member 12) [NCBI Gene 116085] {aka OAT4L, RST, UAT, URAT1, hURAT1}, CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, PPP1R7 (protein phosphatase 1 regulatory subunit 7) [NCBI Gene 5510] {aka SDS22}, HGFAC (HGF activator) [NCBI Gene 3083] {aka HGFA}, UGT1A9 (UDP glucuronosyltransferase family 1 member A9) [NCBI Gene 54600] {aka HLUGP4, LUGP4, UDPGT, UDPGT 1-9, UGT-1I, UGT1-09}, NKD1 (NKD inhibitor of Wnt signaling pathway 1) [NCBI Gene 85407] {aka Naked1}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, UGT1A7 (UDP glucuronosyltransferase family 1 member A7) [NCBI Gene 54577] {aka UDPGT 1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G}, LINC00683 (long intergenic non-protein coding RNA 683) [NCBI Gene 400660], IRX3 (iroquois homeobox 3) [NCBI Gene 79191] {aka IRX-1, IRXB1}, EDA2R (ectodysplasin A2 receptor) [NCBI Gene 60401] {aka EDA-A2R, EDAA2R, TNFRSF27, XEDAR}, HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) [NCBI Gene 8630] {aka HSE, RODH, SDR9C6}, PTCHD4 (patched domain containing 4) [NCBI Gene 442213] {aka C6orf138, PTCH53, SLC65C2, dJ402H5.2}, SPATA18 (spermatogenesis associated 18) [NCBI Gene 132671] {aka Mieap, SPETEX1}, ODAM (odontogenic, ameloblast associated) [NCBI Gene 54959] {aka APIN}, CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, PGM5P4-AS1 (PGM5P4 antisense RNA 1) [NCBI Gene 103344932] {aka FAM233C}, ALDH3A1 (aldehyde dehydrogenase 3 family member A1) [NCBI Gene 218] {aka ALDH3, ALDHIII}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, KCNIP3 (potassium voltage-gated channel interacting protein 3) [NCBI Gene 30818] {aka CSEN, DREAM, KCHIP3}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}, REG3A (regenerating family member 3 alpha) [NCBI Gene 5068] {aka HIP, HIP/PAP, INGAP, PAP, PAP-H, PAP1}, TOP2A (DNA topoisomerase II alpha) [NCBI Gene 7153] {aka TOP2, TOP2alpha, TOPIIA, TP2A}, GABRA3 (gamma-aminobutyric acid type A receptor subunit alpha3) [NCBI Gene 2556] {aka EPILX2}, GABRA2 (gamma-aminobutyric acid type A receptor subunit alpha2) [NCBI Gene 2555] {aka DEE78, EIEE78}, BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) [NCBI Gene 701] {aka BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1}, ACSL6 (acyl-CoA synthetase long chain family member 6) [NCBI Gene 23305] {aka ACS2, FACL6, LACS 6, LACS2, LACS5}, CXCL6 (C-X-C motif chemokine ligand 6) [NCBI Gene 6372] {aka CKA-3, GCP-2, GCP2, SCYB6}, ASGR1 (asialoglycoprotein receptor 1) [NCBI Gene 432] {aka ASGPR, ASGPR1, CLEC4H1, HL-1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CDC20 (cell division cycle 20) [NCBI Gene 991] {aka CDC20A, OOMD14, OZEMA14, bA276H19.3, p55CDC}, SLC22A11 (solute carrier family 22 member 11) [NCBI Gene 55867] {aka OAT4, hOAT4}, ASGR2 (asialoglycoprotein receptor 2) [NCBI Gene 433] {aka ASGP-R2, ASGPR2, CLEC4H2, HBXBP, HL-2}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}
- **Diseases:** lung cancer (MESH:D008175), Cancer (MESH:D009369), liver and intestinal tumors (MESH:D007414), injury (MESH:D014947), inflammatory (MESH:D007249), prostate cancer (MESH:D011471), hepatocellular adenomas and carcinomas (MESH:D018248), cervical cancer (MESH:D002583), Metabolic (MESH:D008659), non-small cell lung cancer (MESH:D002289), gallbladder cancer (MESH:D005706), CLAM (MESH:D007859), tumorigenesis (MESH:D063646), cholestasis (MESH:D002779), metastasis (MESH:D009362), colorectal cancer (MESH:D015179), HCC (MESH:D006528), WSI (MESH:C564543), aneuploidy (MESH:D000782), renal cell carcinoma (MESH:D002292), vascular invasion (MESH:D009361), breast cancer (MESH:D001943), liver (MESH:D017093)
- **Chemicals:** paraffin (MESH:D010232), aflatoxin B1 (MESH:D016604), GABA (MESH:D005680), glutamate (MESH:D018698), ethanol (MESH:D000431), chloride (MESH:D002712), amino acid (MESH:D000596), fatty acid (MESH:D005227), CLAM (-), H&amp;E (MESH:D006371), bile acids (MESH:D001647), alcohol (MESH:D000438), glucose (MESH:D005947), formalin (MESH:D005557), ROS (MESH:D017382), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** AC112206 — Homo sapiens (Human), Transformed cell line (CVCL_HA69)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940783/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940783/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940783/full.md

---
Source: https://tomesphere.com/paper/PMC12940783